Institutional, Investors

Institutional Investors Double Down on Strategy Shares Amid Bitcoin Volatility

01.03.2026 - 00:33:42 | boerse-global.de

Major funds like Amundi boost stakes in Strategy as a Bitcoin proxy, even as its share price falls due to crypto market weakness and dilution concerns.

While the share price of Strategy faces significant pressure from declining cryptocurrency markets, a notable counter-trend is emerging: major institutional players are aggressively increasing their stakes. This divergence highlights the complex investment thesis surrounding the company, which serves as a regulated proxy for Bitcoin exposure.

Major Fund Managers Expand Holdings

Recent regulatory filings reveal substantial buying from two prominent institutions. European asset management giant Amundi significantly bolstered its position in the fourth quarter of 2025. According to a 13F filing, Amundi purchased approximately 3.77 million additional shares, marking an increase of 373%. This acquisition brings its total holding to nearly 4.8 million shares, valued at roughly $728 million USD at the time of the filing.

Trading firm Jane Street Group also dramatically raised its exposure, boosting its position by 473% to about 951,000 shares, worth approximately $121 million USD. The common rationale appears to be Strategy's role as a liquid, exchange-traded avenue for Bitcoin investment—a more operationally straightforward vehicle for large funds than holding cryptocurrencies directly.

The Core Pressure: Bitcoin's Price Versus Cost Basis

Strategy's fortunes remain tethered to Bitcoin's market price, creating a fundamental tension. As of February 28, the company held 717,722 BTC. However, its average purchase price sits near $76,020 per Bitcoin. With Bitcoin referenced in the source material at around $65,702, this gap implies Strategy requires a roughly 15% upward move in Bitcoin's price to reach its average cost basis.

This dynamic explains why institutional accumulation and short-term share price weakness can coexist. Investors using Strategy primarily as a Bitcoin proxy inherently accept that its shares will be dragged down during crypto market downturns. This correlation is evident in recent performance data, with the stock down approximately 17% over a 30-day period.

Financing Growth: The 100th Purchase and Shareholder Dilution

The company recently announced its 100th Bitcoin purchase, acquiring 592 BTC for about $39.8 million USD. This acquisition was funded partly through the sale of roughly 297,940 common shares. Herein lies a critical consideration for shareholders: Strategy's model is committed to accumulating Bitcoin, but repeated equity sales to finance this growth can lead to share dilution.

Should investors sell immediately? Or is it worth buying Strategy?

Financing complexity is also increasing. Strategy raised the annual dividend rate on its Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) from 11.00% to 11.25%. For the month ending February 28, a cash dividend of $0.9375 per STRC share was declared. While such preferred shares provide capital, they also create claims that rank above those of common stockholders.

Q4 2025 Results: Revenue Beat Overshadowed by Substantial Loss

Financial results for the fourth quarter of 2025, filed on February 5, 2026, presented a stark contrast. Revenue came in at $123 million USD, surpassing the $118.5 million USD expectation. Yet, the bottom line showed a net loss of $12.44 billion USD, driven primarily by an unrealized loss of $17.44 billion USD on digital assets.

The message is clear: the income statement is increasingly dominated by Bitcoin price fluctuations and their accounting treatment, while operational business performance recedes in importance. This amplifies volatility, both fundamentally and in market sentiment.

Consequently, the focus for the second quarter of 2026 will likely hinge on two factors: whether Bitcoin can sustainably recover above Strategy's average cost basis, and how aggressively the company continues to fund purchases through share sales and "at-the-market" offering programs.

Ad

Strategy Stock: New Analysis - 1 March

Fresh Strategy information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Strategy analysis...

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr.
Jetzt abonnieren.

US5949724083 | INSTITUTIONAL | boerse | 68622617 |